Daniel Hubschmann

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts.

Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts.

Journal: Science translational medicine

Published: May 13, 2026

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretion.

Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretion.

Journal: Scientific reports

Published: November 12, 2025

Germany's national genomDE strategy.

Germany's national genomDE strategy.

Journal: Nature medicine

Published: October 15, 2025

Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities.

Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities.

Journal: ESMO open

Published: September 16, 2025

Compartment-Specific NK Cell Phenotypes Reveal Distinct Maturation and Activation States in Inflammatory Arthritis.

Compartment-Specific NK Cell Phenotypes Reveal Distinct Maturation and Activation States in Inflammatory Arthritis.

Journal: Journal of innate immunity

Published: August 02, 2025

Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trial.

Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trial.

Journal: Cancer treatment and research communications

Published: July 29, 2025

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Journal: Med (New York, N.Y.)

Published: July 27, 2025

Multimodal plasma and urinary cell-free DNA profiling improves risk stratification in newly diagnosed prostate cancer.

Multimodal plasma and urinary cell-free DNA profiling improves risk stratification in newly diagnosed prostate cancer.

Journal: NPJ precision oncology

Published: July 08, 2025

Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma.

Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma.

Journal: JCO precision oncology

Published: July 02, 2025

A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells.

A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells.

Journal: Nature cell biology

Published: June 30, 2025

Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience.

Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience.

Journal: International journal of cancer

Published: June 27, 2025

Showing 1-12 of 114

Last Updated: 09/26/2026